JAMA+ AI Weekly Update: September 13, 2025

In this special edition of JAMA+ AI Conversations, Editor in Chief Roy Perlis, MD, MSc, is joined by Linda Brubaker, MD, MS, Editor in Chief of JAMA+ Women’s Health and Deputy Editor at JAMA.

They speak with Linda Moy, inaugural vice chair of AI for the NYU Department of Radiology and former editor of Radiology, about the opportunities and risks of applying AI in medical imaging.

Will these new tools be a net positive for women’s health?

Learn more and listen to the podcast.

Editor’s Picks in this week’s JAMA+ AI: 

• FDA-cleared AI medical devices often experience recalls shortly after clearance, particularly those without clinical validation and produced by publicly traded companies. (JAMA Health Forum)
• In a letter responding to a recent JAMA Viewpoint, the authors commend the launch of the Trustworthy and Responsible AI Network but raise concerns about its lack of diverse leadership. (JAMA)
• Model drift—when prediction models lose accuracy over time—can undermine clinical care and policy decisions. The authors urge proactive monitoring and regulation to ensure AI models remain effective. (JAMA Health Forum)